Autopsy report · NCT01452854

Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide

“Low recruitment, sponsor withdrew funding.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 2 participants enrolled.
• Results were posted on the registry 9 months after it ended.

Vital statistics

Status

Terminated

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Low Grade Glioma

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding
  “Sponsor withdrew funding.” (80% match in meaning)
• In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA
  “Funding withdrawn, no participants recruited” (78% match in meaning)
• Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
  “Low recruitment, insufficient funding” (77% match in meaning)
• High-intensity Exercise After Acute Cardiac Event (HITCARE)
  “Recruitment was stopped due to lack of funding.” (77% match in meaning)
• Digital Prevention of Asthma
  “The recruitment stopped due insufficient funding.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.